SAB BIOTHERAPEUTICS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | 37.2% | 36.4% |
| FY2021 | — | -22.0% | -28.2% |
| FY2022 | — | -121.0% | -78.4% |
| FY2023 | — | -1,700.6% | -1,884.5% |
| FY2024 | — | -3,244.9% | -2,579.0% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2020 | — | 37.2% | 36.4% |
| FY2021 | — | -22.0% | -28.2% |
| FY2022 | — | -121.0% | -78.4% |
| FY2023 | — | -1,700.6% | -1,884.5% |
| FY2024 | — | -3,244.9% | -2,579.0% |